Susan Vanbeuge
Family · Las Vegas, NVNPI 1174501720
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (54.6%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 25 manufacturers reported payments, led by Acella Pharmaceuticals, LLC at 54.6% of the total. Reporting peaked in 2022 at $6,127 and has fallen 92.3% since, to $475 in 2025. Among family clinicians in NV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 66 payments — averaging $165.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Acella Pharmaceuticals, LLC$6K
- Novo Nordisk$1K
- AstraZeneca$639
- Alfasigma USA, Inc.$600
- Boehringer Ingelheim$365
- Abbott$299
- plus $2K from 19 others
What the payments were for
- Consulting fees$1,40513%
- Speaking & faculty fees$5,95955%
- Food & beverage$3,54432%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Acella Pharmaceuticals, LLC | 3 | $5,959 |
| Novo Nordisk | 13 | $1,407 |
| AstraZeneca | 12 | $639 |
| Alfasigma USA, Inc. | 1 | $600 |
| Boehringer Ingelheim | 4 | $365 |
| Abbott | 4 | $299 |
| GSK | 3 | $246 |
| Novartis | 2 | $207 |
| Daiichi Sankyo Inc. | 2 | $155 |
| Esperion Therapeutics, Inc. | 1 | $125 |
| Johnson & Johnson | 1 | $125 |
| Argenx US, Inc. | 1 | $120 |
| Bayer | 1 | $107 |
| Ultragenyx Pharmaceutical Inc. | 1 | $102 |
| Biogen | 1 | $92 |
| Medtronic | 3 | $69 |
| Currax Pharmaceuticals LLC | 1 | $53 |
| Amarin Pharma, Inc. | 3 | $51 |
| Lilly USA, LLC | 2 | $49 |
| Radius Health, Inc. | 2 | $32 |
| Corcept Therapeutics | 1 | $26 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
| Dexcom, Inc. | 1 | $23 |
| AbbVie | 1 | $20 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NP Thyroid 60$5,959
- Ozempic$912
- JARDIANCE$346
- FREESTYLE LIBRE 3$263
- FARXIGA$241
- BEXSERO$234
- INJECTAFER$135
- XARELTO$125
- NEXLIZET$125
- NEXLETOL$125
- RYBELSUS$124
- Wegovy$124
- VYVGART HYTRULO$120
- LEQVIO$114
- ENTRESTO$114
- Kerendia$107
- DOJOLVI$102
How this compares
$10,908 in reported general payments places this provider in the 95th percentile of 1,501 family providers in Nevada.
Other family in Las Vegas
- Hollie TylerLas Vegas$118K
- John PhoenixLas Vegas$107K
- Jon FaillaLas Vegas$74K
- Alex LapasaranLas Vegas$50K
- Erin WilkinsonLas Vegas$43K
- Anna Melisa Lopez-SanglayLas Vegas$42K
- Kelly PapeshLas Vegas$28K
- Bernard BlanksLas Vegas$26K
- Hillary DursteinLas Vegas$21K
- Victoria HughesLas Vegas$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.